Found 0 matching trials
Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome PHASE2 This is a clinical trial to be conducted at multiple sites in the USA. Pati...
Show More Location
HOPE Research Institute
Learn More & Join Trial
Effects of Transcutaneous Vagus Nerve Stimulation in Chronic Pain Patients and Healthy Controls NA The tVNS-PP trial investigates the effects of transcutaneous vagus nerve st...
Show More Location
University Medical Center
Learn More & Join Trial
Ecological Momentary Assessment in Patients With Restless Legs Syndrome NA The Restless Legs Syndrome (RLS) is a sensorimotor disorder better characte...
Show More Location
CHU de Bordeaux - Neurophysiologie Clinique de l'Enfant et de l'Adulte
Learn More & Join Trial
A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.) PHASE3 The primary objective is to assess sustained efficacy in patients who have ...
Show More Location
Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Effect of Intra-Dialytic Muscle Energy Technique on Restless Leg Syndrome in Hemodialysis Patients NA The goal of this clinical trial is to learn if intra-dialytic Muscle Energy...
Show More Location
Tala Central Hospital
Learn More & Join Trial
Right to Left Cardiac Shunt Detection PHASE3 The purpose of this study is to evaluate the sensitivity and specificity of...
Show More Location
Heart and Vascular Center of Arizona
Learn More & Join Trial
Sleep and Circadian Intervention Program for Chronic Musculoskeletal Pain NA Musculoskeletal pain has become in a major problem related to its prevalenc...
Show More Location
Hospital Universitario de Guadalajara
Learn More & Join Trial
Sleep Deficiency and Stroke Outcome N/A Deficient sleep duration and sleep disturbances - such as insomnia, sleep d...
Show More Location
Department of Neurology Inselspital, Bern University Hospital
Learn More & Join Trial
Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS) PHASE3 To determine efficacy and safety of Pramipexole 0.125mg to 0.75mg daily for...
Show More Location
248.630.04 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients PHASE2 The primary objective of this study is to investigate efficacy and safety o...
Show More Location
Multiple Locations
Learn More & Join Trial